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Letter to the Editor
Antibody-guided lymphangiography in the staging of
cervical cancer
Sir-We read with interest the report on antibody
guided lymphangiography in the staging of cervical
cancer (Epenetos, 1985).
The author reports the occurrence of non specific
isotope uptake by pelvic lymph nodes in patients
presented to be free of nodal metastasis (as judged
by concomitant X-ray lymphangiography). Non
specific antibody binding through the Fc portion of
the immunoglobulin was postulated as the cause of
this phenomenon.
We would suggest, however, that the effect may
be partly explained by the presence of X-ray
contrast medium in the lymphatics. We have
performed similar antibody studies using a
polyclonal anti CEA antibody linked to iodine131.
Figure 1 illustrates the gamma camera image of the
anterior pelvis 24h following injection of labelled
antibody in a patient with Stage Ib carcinoma of
the cervix. There is a difference between the two
sides of the pelvis on this scan with small discrete
areas of uptake on the right but broader more
diffuse areas of uptake on the left. Subsequent
pelvic lymphadenectomy revealed no evidence of
lymph node metastases. Standard bipedal X-ray
lymphangiography had been performed in this case
but technical problems had prevented an adequate
infusion of Lipiodol into the lymphatics of the right
leg and this fact may explain the asymmetry seen
on the antibody guided scan. This is compatible
with the known occurrence of lymph node
enlargement and lymphatic stasis following
lymphangiography with lipid soluble contrast
medium (Spitalier et al., 1967; Wallace et al., 1979).
Figure 1 Antibody guided lymphangiography. Anterior pelvic scan at 24h. There is an asymmetrical
appearance of the right and left nodal groups.706 LETTER TO THE EDITOR
We would suggest that this effect of stasis and
nodal enlargement should be borne in mind when
interpreting antibody guided scans.
Yours etc.,
N. Saunders, M.E.L. Paterson & S. Sherriff,
Northern General Hospital,
Sheffield, UK.
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Dr Epenetos replies:
Sir-Thank you for bringing to our attention the
letter of Saunders et al. in which it is stated that
non-specific antibody binding in the pelvic lymph
nodes may be partly explained by the presence of
X-ray contrast medium in the lymphatics. Certainly
their studies of using a polyclonal anti CEA
antibody linked to iodine-131 concurrently with
bipedal X-ray lymphangiography demonstrate that
lipid-soluble contrast medium can interfere with
antibody localisation as shown by their illustrated
example. We agree therefore with them that X-ray
contrast medium can be a further factor in non-
specific antibody capture by lymphatics. Since our
last report on antibody guided lymphangiography
(Epenetos, 1985) we have performed further
lymphangiography but on this occasion adminis-
tering radiolabelled antibody subcutaneously
without injection of contrast. We have seen again
non-specific antibody capture by lymphatics but
our data so far would indicate that this capture is
less than when the antibody was injected during
lymphangiography, pointing again to the fact that
X-ray contrast medium interferes with radio-
immunolocalisation.
We also noted that the use of indium-labelled
monoclonal antibodies given subcutaneously causes
more marked imaging of local lymphatics as
compared to iodinated antibody. This is probably
due to the different kinetics of the various
radiolabels after antibody breakdown. We still
believe that the best way to sort out specific and
non-specific binding is to perform immuno-
lymphangiography using a specific antibody
followed by a non-specific antibody.
Yours etc.,
A.A. Epenetos
Royal Postgraduate Medical School,
Hammersmith Hospital,
London W12 OHS
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